Related Experiment Video
Updated: Jul 5, 2025
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
86.0K
Pediatric contributions and lessons learned from the NEPTUNE cohort study
Zubin J Modi1,2, Yan Zhai1, Jennifer Yee1
1Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Pediatric Nephrology (Berlin, Germany)
|January 17, 2024
Summary
The NEPTUNE network studies rare glomerular diseases in patients of all ages. This research aims to create a molecular classification and guide precision medicine through detailed data collection and analysis.
Area of Science:
- Nephrology
- Rare Diseases
- Genomics
Background:
- Primary glomerular diseases are rare, hindering research into their pathobiology and treatment development.
- Existing classification relies on traditional pathology, limiting understanding of disease mechanisms.
Purpose of the Study:
- To establish a molecular classification for primary glomerular diseases, moving beyond traditional pathological features.
- To leverage multi-scalar patient data for precision medicine approaches in rare kidney disorders.
- To provide insights into the pediatric population within the NEPTUNE cohort.
Main Methods:
- Longitudinal cohort study collecting demographic, clinical, histopathologic, genomic, transcriptomic, and metabolomic data.
- Analysis of data from patients with minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.
- Development of NEPTUNE Match to guide clinical trial participation based on molecular profiles.
Main Results:
- Detailed data accumulated on patients of all ages, including children and adolescents.
- Key observations derived from the NEPTUNE cohort data.
- Establishment of NEPTUNE Match for precision medicine in primary glomerular diseases.
Conclusions:
- The NEPTUNE network is crucial for advancing the study of glomerular diseases across all age groups.
- Molecular classification and precision medicine hold promise for treating rare kidney disorders.
- NEPTUNE's comprehensive data collection facilitates novel therapeutic strategies.
